Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

The EZH2 selective inhibitor ZLD1039 attenuates UUO-induced renal fibrosis by suppressing YAP activation

Open access
Xia, Qingling, Xu, Fujiang, Zhang, Lidan, Ding, Wenfei, Liu, Jiang, Liu, Jing, Chen, Minhao, Ou, Santao, Xu, Yong, Wen, Li · 2025 · Molecular Biomedicine

Abstract

Renal fibrosis is a manifestation of the progression of chronic kidney disease (CKD) and chronic inflammation is a main driver in the development of renal fibrosis. Yes-associated protein (YAP), acting as a transcriptional co-activator within the Hippo signaling pathway, has been implicated in renal fibrosis. Enhancer of zeste homolog 2 (EZH2) exhibits high expression level in renal fibrosis induced by unilateral ureteral obstruction (UUO), yet the interplay between YAP and EZH2 in renal fibrosis remains to be elucidated. ZLD1039, a selective inhibitor of EZH2, has demonstrated protective effects against cancer and acute kidney injury (AKI). In this study, we conducted a systemic pharmacological investigation to determine if ZLD1039 treatment mitigates UUO-induced renal inflammation and fibrosis through modulation of the Hippo-YAP pathway. Our results revealed that UUO triggered renal inflammation and collagen deposition, with significant activation of YAP. Notably, ZLD1039 treatment effectively alleviated renal inflammation and fibrosis, while inhibiting the expression and nuclear translocation of YAP. Mechanically, we observed a notable down-regulation of large tumor suppressor homolog 1 (LATS1) in parallel with the up-regulation of EZH2. Furthermore, inhibition of EZH2 by ZLD1039 was linked to the up-regulation of LATS1 expression and YAP inactivation. Similarly, in vitro pharmacological inhibition of EZH2 by ZLD1039 resulted in elevated LATS1 expression and diminished YAP activation. Collectively, our findings suggest that ZLD1039, a selective inhibitor of EZH2, likely attenuates renal inflammation and fibrosis probably by up-regulating LATS1 and inhibiting YAP activation. This mechanistic link between EZH2 and YAP provides a fresh perspective on treating renal fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s43556-025-00276-5

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 ZLD1039 inhibits UUO-induced renal fibrosis. a The appearance of kidney tissues following unilateral ureteral ligation; b, c Representative sections of H&E staining of kidney tissues (original magnification × 200) and renal tubular injury scores were calculated according to the criterion in materials and methods; Data are represented as means ± SDs (n = 6); d, e Representative sections of Masson’s trichrome staining of kidney tissues (original magnification × 200) and renal fibrosis scores were calculated. Data are represented as means ± SDs (n = 3); f, g The mRNA levels of FN and α-SMA; Data are represented as means ± SDs (n = 6); h, i Representative sections of IHC staining of FN (original magnification × 200) and mean optical density of FN; j, k Representative sections of IHC staining of α-SMA (original magnification × 200) and mean optical density of α-SMA; Data are represented as means ± SDs (n = 3); l The protein expression levels of FN and α-SMA were quantified by normalized with β-actin. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. All western blotting analyses were performed in two randomized mice from each group, and the experiments were repeated in triplicate
Fig. 1 ZLD1039 inhibits UUO-induced renal fibrosis. a The appearance of kidney tissues following unilateral ureteral ligation; b, c Representative sections of H&E staining of kidney tissues (original magnification × 200) and renal tubular injury scores were calculated according to the criterion in materials and methods; Data are represented as means ± SDs (n = 6); d, e Representative sections of Masson’s trichrome staining of kidney tissues (original magnification × 200) and renal fibrosis scores were calculated. Data are represented as means ± SDs (n = 3); f, g The mRNA levels of FN and α-SMA; Data are represented as means ± SDs (n = 6); h, i Representative sections of IHC staining of FN (original magnification × 200) and mean optical density of FN; j, k Representative sections of IHC staining of α-SMA (original magnification × 200) and mean optical density of α-SMA; Data are represented as means ± SDs (n = 3); l The protein expression levels of FN and α-SMA were quantified by normalized with β-actin. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. All western blotting analyses were performed in two randomized mice from each group, and the experiments were repeated in triplicateCC BY · PubMed Central
Fig.2 ZLD1039 indeed suppresses EZH2 and H3K27me3 expression in UUO rats. a The mRNA level of EZH2; b-e Photomicrographs (original magnification × 200) illustrates EZH2 and H3K27me3 IHC staining of kidney tissues from sham or UUO mice with/without ZLD1039 administration and the mean optical density of EZH2 and H3K27me3; Data are represented as means ± SDs (n = 3); f The protein expression levels of EZH2 and H3K27me3 were quantified by normalized with β-actin and Histone H3; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. All western blotting analyses were performed in two randomized mice from each group, and the experiments were repeated in triplicate
Fig.2 ZLD1039 indeed suppresses EZH2 and H3K27me3 expression in UUO rats. a The mRNA level of EZH2; b-e Photomicrographs (original magnification × 200) illustrates EZH2 and H3K27me3 IHC staining of kidney tissues from sham or UUO mice with/without ZLD1039 administration and the mean optical density of EZH2 and H3K27me3; Data are represented as means ± SDs (n = 3); f The protein expression levels of EZH2 and H3K27me3 were quantified by normalized with β-actin and Histone H3; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. All western blotting analyses were performed in two randomized mice from each group, and the experiments were repeated in triplicateCC BY · PubMed Central
Fig.3 EZH2 inhibition by ZLD1039 attenuates renal inflammation in UUO rats. a-c The mRNA levels of IL-1β, IL-6 and TNFα; Data are represented as means ± SDs (n = 6); d, g Representative sections of IHC staining of IL-1β (original magnification × 200) and the mean optical density of IL-1β; e, h Representative sections of IHC staining of IL-6 (original magnification × 200) and the mean optical density of IL-6; f, i Representative sections of IHC staining of TNFα (original magnification × 200) and the mean optical density of TNFα; Data are represented as means ± SDs (n = 3); j The protein expression levels of IL-1β, IL-6 and TNFα were quantified by normalized with β-actin; ** p < 0.01; *** p < 0.001; **** p < 0.0001. All western blotting analyses were performed in two randomized mice from each group, and the experiments were repeated in triplicate
Fig.3 EZH2 inhibition by ZLD1039 attenuates renal inflammation in UUO rats. a-c The mRNA levels of IL-1β, IL-6 and TNFα; Data are represented as means ± SDs (n = 6); d, g Representative sections of IHC staining of IL-1β (original magnification × 200) and the mean optical density of IL-1β; e, h Representative sections of IHC staining of IL-6 (original magnification × 200) and the mean optical density of IL-6; f, i Representative sections of IHC staining of TNFα (original magnification × 200) and the mean optical density of TNFα; Data are represented as means ± SDs (n = 3); j The protein expression levels of IL-1β, IL-6 and TNFα were quantified by normalized with β-actin; ** p < 0.01; *** p < 0.001; **** p < 0.0001. All western blotting analyses were performed in two randomized mice from each group, and the experiments were repeated in triplicateCC BY · PubMed Central
Fig.4 EZH2 inhibition by ZLD1039 increases LATS1 expression in UUO rats. a The mRNA level of LATS1; Data are represented as means ± SDs (n = 6); b Representative sections of IHC staining of p-LATS1 (original magnification × 200). c The protein expression level of LATS1 and p-LATS1 were quantified by normalized with β-actin; d The protein expression level of p-LATS1 were quantified by normalized with LATS1; * p < 0.05; **** p < 0.0001. All western blotting analyses were performed in two randomized mice from each group, and the experiments were repeated in triplicate
Fig.4 EZH2 inhibition by ZLD1039 increases LATS1 expression in UUO rats. a The mRNA level of LATS1; Data are represented as means ± SDs (n = 6); b Representative sections of IHC staining of p-LATS1 (original magnification × 200). c The protein expression level of LATS1 and p-LATS1 were quantified by normalized with β-actin; d The protein expression level of p-LATS1 were quantified by normalized with LATS1; * p < 0.05; **** p < 0.0001. All western blotting analyses were performed in two randomized mice from each group, and the experiments were repeated in triplicateCC BY · PubMed Central
Fig.5 EZH2 inhibition by ZLD1039 blocks YAP activation in UUO rats. a, b The cluster heatmap and correlation heatmap were conducted to present differentially expressed genes in the GSE181380 dataset (n = 3). c The protein expression levels of YAP, p-YAP and TEAD1 were quantified by normalized with β-actin; d The protein expression level of p-YAP were quantified by normalized with YAP; All western blotting analyses were performed in two randomized mice from each group, and the experiments were repeated in triplicate
Fig.5 EZH2 inhibition by ZLD1039 blocks YAP activation in UUO rats. a, b The cluster heatmap and correlation heatmap were conducted to present differentially expressed genes in the GSE181380 dataset (n = 3). c The protein expression levels of YAP, p-YAP and TEAD1 were quantified by normalized with β-actin; d The protein expression level of p-YAP were quantified by normalized with YAP; All western blotting analyses were performed in two randomized mice from each group, and the experiments were repeated in triplicateCC BY · PubMed Central
Fig.6 ZLD1039 alleviates TGFβ-induced renal TECs inflammation and fibrosis by inhibiting EZH2 and elevating the expression of LATS1. a The cell viability of TECs under the stimulation of TGFβ and ZLD1039. Data are represented as means ± SDs (n = 6); b-e, f-i The mRNA levels of FN, α-SMA, IL-1β, IL-6, TNFα, EZH2 and LATS1; Data are represented as means ± SDs (n = 6); d The protein expression levels of FN, α-SMA, IL-1β, IL-6, TNFα, EZH2, H3K27me3, LATS1 and p-LATS1 were quantified by normalized with β-actin; j The protein expression level of p-LATS1 were quantified by normalized with LATS1 in TGFβ-induced TECs; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; nsp > 0.05. All Western Blotting analyses were repeated in triplicate
Fig.6 ZLD1039 alleviates TGFβ-induced renal TECs inflammation and fibrosis by inhibiting EZH2 and elevating the expression of LATS1. a The cell viability of TECs under the stimulation of TGFβ and ZLD1039. Data are represented as means ± SDs (n = 6); b-e, f-i The mRNA levels of FN, α-SMA, IL-1β, IL-6, TNFα, EZH2 and LATS1; Data are represented as means ± SDs (n = 6); d The protein expression levels of FN, α-SMA, IL-1β, IL-6, TNFα, EZH2, H3K27me3, LATS1 and p-LATS1 were quantified by normalized with β-actin; j The protein expression level of p-LATS1 were quantified by normalized with LATS1 in TGFβ-induced TECs; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; nsp > 0.05. All Western Blotting analyses were repeated in triplicateCC BY · PubMed Central
Fig.7 ZLD1039 treatment represses YAP activation in TGFβ-induced TECs. a The protein expression levels of YAP, p-YAP and TEAD1 were quantified by densitometry and normalized with β-actin; b The expression levels of YAP in cytoplasm and nucleus; c,d The interactions between EZH2 and YAP were detected by Co-Immunoprecipitation (Co-IP) in NRK-52E cells. e The protein expression level of p-YAP was quantified by normalized with YAP in TGFβ-induced TECs; f The interaction between EZH2 and the Hippo pathway in UUO-induced renal fibrosis (This picture is drawn using Figdraw). All Western Blotting analyses were repeated in triplicate
Fig.7 ZLD1039 treatment represses YAP activation in TGFβ-induced TECs. a The protein expression levels of YAP, p-YAP and TEAD1 were quantified by densitometry and normalized with β-actin; b The expression levels of YAP in cytoplasm and nucleus; c,d The interactions between EZH2 and YAP were detected by Co-Immunoprecipitation (Co-IP) in NRK-52E cells. e The protein expression level of p-YAP was quantified by normalized with YAP in TGFβ-induced TECs; f The interaction between EZH2 and the Hippo pathway in UUO-induced renal fibrosis (This picture is drawn using Figdraw). All Western Blotting analyses were repeated in triplicateCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Metadata

Authors
Xia, Q., Xu, F., Zhang, L., Ding, W., Liu, J., Liu, J., Chen, M., Ou, S., Xu, Y., & Wen, L.
Affiliations
  • Southwest Medical University (CN)
  • West China Hospital of Sichuan University (CN)
Corresponding author
  • Ou, Santao
  • Xu, Yong
  • Wen, Li
Venue
Molecular Biomedicine
Published
2025-06-06
Volume
6
Issue
1
Pages
36-36
ISSN
2662-8651 (ISSN-L)
OpenAlex
W4411109894
Cited by
7
References
40
Citations by year
2026: 6 · 2025: 1
FWCI
3.47
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Biomedicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Natural Science Foundation of Sichuan Province (2023NSFSC1530)
  • Luzhou Science and Technology Bureau (2023JYJ018)
  • School-Level Scientific Research Project of the Southwest Medical University (2022ZD005)
  • Luzhou Science and Technology Program (2023JYJ008)
  • China Postdoctoral Science Foundation (2023M742905)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
EZH2 inhibitors, renal fibrosis, YAP activation, Hippo signaling pathway, LATS1, unilateral ureteral obstruction, renal inflammation, collagen deposition, chronic kidney disease, acute kidney injury
MeSH terms
Enhancer of Zeste Homolog 2 Protein, YAP-Signaling Proteins, Animals, Fibrosis, Kidney, Kidney Diseases, Male, Mice, Inbred C57BL, Transcription Factors, Ureteral Obstruction, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Adaptor Proteins, Signal Transducing, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The EZH2 selective inhibitor ZLD1039 attenuates UUO-induced renal fibrosis by suppressing YAP activation. https://app.cochat.ai/papers/10.1186/s43556-025-00276-5
The paper
Xia, Q., Xu, F., Zhang, L., Ding, W., Liu, J., Liu, J., Chen, M., Ou, S., Xu, Y., & Wen, L. (2025). The EZH2 selective inhibitor ZLD1039 attenuates UUO-induced renal fibrosis by suppressing YAP activation. Molecular Biomedicine. https://doi.org/10.1186/s43556-025-00276-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.